A kind of amplification-free nucleic acid detection method and its application

By combining CRISPR technology and digital microfluidic control technology on the microarray chip, nucleic acid detection is directly carried out in the micropore, solving the problems of cumbersome detection process and insufficient sensitivity in the existing technology, and achieving high sensitivity to the new coronavirus. Fast and accurate detection.

CN114540547BActive Publication Date: 2024-11-12SOUTHERN UNIVERSITY OF SCIENCE AND TECHNOLOGY
0 Cites 1 Cited by

Patent Information

Application Number
CN202210180046.0
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-02-25
Publication Date
2024-11-12
Estimated Expiration
2042-02-25

AI Technical Summary

Technical Problem

The existing nucleic acid detection methods have problems with cumbersome testing procedures, long time and aerosol contamination caused by nucleic acid amplification in the early diagnosis of novel coronavirus pneumonia, and the sensitivity of the amplification-free technology is not enough to meet clinical needs.

Method used

Micron-level microarray chips are used to realize digital CRISPR detection, and the capture probe reacts with the CRISPR reaction system in the micropores of the microfluidic chip to avoid nucleic acid amplification, improve detection sensitivity and reduce background noise.

Benefits of technology

The detection of nucleic acid molecules as low as 1aM is achieved, which is simple and fast, meets the needs of early clinical diagnosis, and reduces the risk of diffusion dilution and contamination, improving the specificity and accuracy of the detection.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present invention belongs to the field of nucleic acid detection, and discloses an amplification-free nucleic acid detection method and its application. The nucleic acid detection method of the present invention comprises: capturing the nucleic acid to be detected with a capture probe to form a capture probe-to-be-detected nucleic acid complex; mixing the capture probe-to-be-detected nucleic acid complex with the CRISPR reaction system to form a reaction solution, and passing the reaction solution into the micropores of a microfluidic chip for reaction; and microscopically observing the generated fluorescence to determine the nucleic acid detection result. The present invention combines CRISPR technology with microfluidic technology to develop a nucleic acid detection method, which can achieve single-molecule detection of nucleic acid without nucleic acid amplification, is simple and rapid, does not cause aerosol contamination caused by amplifying nucleic acid, has high sensitivity, and can detect nucleic acid molecules at the attomole level, greatly expanding the scope of use.
Need to check novelty before this filing date? Find Prior Art